Related Experiment Video
Updated: May 8, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
The risk stratification based on the CHA₂DS₂-VASc may predict the response to intravenous thrombolysis after stroke
Manuel Cappellari1, Paolo Bovi, Nicola Micheletti
1Stroke Unit, Division of Neurology, Department of Neuroscience, Azienda Ospedaliera Univarsitaria Integrata, Piazzale A. Stefani 1, 37126, Verona, Italy, manuel_cappellari@libero.it.
Insights
The CHA2DS2-VASc score predicts response to intravenous thrombolysis in stroke patients. Low-risk patients benefit most, while very high-risk patients show a failed response to this treatment.
Area of Science:
- Neurology
- Cardiology
- Emergency Medicine
Background:
- The CHA2DS2-VASc score is established for assessing thromboembolic risk in patients with atrial fibrillation (AF).
- Its utility in predicting treatment response to intravenous thrombolysis in acute stroke is less understood.
- Understanding risk stratification may optimize thrombolytic therapy selection and outcomes.
Purpose of the Study:
- To evaluate if prestroke CHA2DS2-VASc score stratification predicts patient response to intravenous (IV) thrombolysis.
- To determine if baseline risk influences outcomes like major improvement or functional status post-thrombolysis.
Main Methods:
- Analysis of prospectively collected data from 516 AF and non-AF stroke patients treated with IV thrombolysis.
- Outcomes assessed at 24 hours (NIHSS score) and 3 months (mRS score).
- Multivariate analysis used to compare outcomes across different CHA2DS2-VASc risk categories.
Main Results:
- Lower odds of major improvement and excellent outcomes were observed in patients with intermediate (CHA2DS2-VASc=1), moderately high (CHA2DS2-VASc=2), and very high (CHA2DS2-VASc>3) risk scores compared to low-risk (CHA2DS2-VASc=0).
- Higher odds of deterioration or unfavorable outcomes were seen only in the very high-risk group.
- A low-risk CHA2DS2-VASc score predicted an effective response to IV thrombolysis.
Conclusions:
- Prestroke CHA2DS2-VASc score is a significant predictor of IV thrombolysis response in stroke patients.
- Low-risk patients are more likely to respond effectively, whereas very high-risk patients have a higher likelihood of failed response.
- Risk stratification using CHA2DS2-VASc may aid in personalizing thrombolytic treatment decisions for stroke patients.
Abstract:
CHA2DS2-VASc score influences the outcome in stroke patients with or without atrial fibrillation (AF). We assessed whether the risk stratification based on the prestroke CHA2DS2-VASc score may predict the response to intravenous (IV) thrombolysis in stroke patients. We conducted an analysis on prospectively collected data of 516 consecutive AF and non-AF patients treated with IV thrombolysis. Outcome measures were major improvement (NIH Stroke Scale [NIHSS] ≤8 points from baseline or NIHSS score 0) and deterioration (death or NIHSS ≥1 points from baseline) or no improvement (NIHSS score equivalent to baseline) at 24 h; excellent (modified Rankin Scale [mRS] score ≤1) and unfavorable outcome (mRS score >2) at 3 months. Multivariate analysis showed that ORs for major improvement and excellent outcome were lower in patients with intermediate risk (CHA2DS2-VASc = 1) (OR 0.39, 95 % CI 0.16-0.92, p = 0.032; OR 0.10, 95 % CI 0.02-0.56, p = 0.009), moderately high risk (CHA2DS2-VASc = 2) (OR 0.43, 95 % CI 0.19-0.96, p = 0.040; OR 0.16, 95 % CI 0.03-0.76, p = 0.022), and very high risk (CHA2DS2-VASc > 3) (OR 0.31, 95 % CI 0.15-0.65, p = 0.002; OR 0.17, 95 % CI 0.04-0.81, p = 0.026), whereas ORs for deterioration or no improvement and unfavorable outcome were higher only in patients with very high risk (OR 4.26, 95 % CI 1.24-14.65, p = 0.021; OR 9.26, 95 % CI 1.15-74.65, p = 0.037), compared with low risk (CHA2DS2-VASc = 0). Low-risk level based on the prestroke CHA2DS2-VASc score was predictor of effective response to IV thrombolysis. Very high-risk level was predictor of failed response, compared with low-risk level.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies